Participant: Healthy individualsIntervention: Seaweed extractComparator: Dose comparisonOutcome: In vivo changes in lymphocyte subsets and ex vivo changes in lymphocyte activation, phagocytosis of granulocytes and monocytes, and T helper1/T helper 2 cytokines.

Marinova Pty Ltd0 个研究点目标入组 10 人开始时间: 2007年5月1日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•Individuals willing to cease all medications over the course of the study, excluding medications for acute conditions such as pain or dyspepsia.

•Individuals taking antioxidant medications and/or supplementsIndividuals with poor venous accessIndividuals with auto-immune disordersIndividuals taking steroid medication or NSAID (non steroidal anti inflammatory drugs)treatmentsIndividuals with diabetesIndividuals taking anticoagulantsIndividuals taking immune suppressant drugsIndividuals taking cytokine or interferon therapyIndividuals taking Echinacea or other immune stimulating herbsIndividuals with clinically abnormal liver function tests at baselineIndividuals who develop a cold or other acute URTI (upper respiratory tract infection) or influenza during the course of the studyIndividuals unwilling to have blood taken 4 times during the studyIndividuals unwilling to comply with the study protocolsIndividuals with any other condition which in the opinion of the researchers could compromise the study.

发起方